Ground Swell Capital LLC Makes New $450,000 Investment in The Cooper Companies, Inc. (NASDAQ:COO)

Key Points

• Ground Swell Capital LLC has acquired a new stake in The Cooper Companies, Inc., purchasing 5,339 shares valued at approximately $450,000, making it the firm's 25th largest holding.
• Institutional investors now own 24.39% of Cooper Companies, with several making new positions or increasing stakes in the company during the first quarter of the year.
• Analysts give Cooper Companies a consensus rating of "Moderate Buy", with an average price target of $96.73, though some have set targets as high as $100.00.

Ground Swell Capital LLC bought a new stake in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 5,339 shares of the medical device company's stock, valued at approximately $450,000. Cooper Companies accounts for approximately 1.0% of Ground Swell Capital LLC's holdings, making the stock its 25th largest position.

Other large investors have also recently bought and sold shares of the company. Covestor Ltd boosted its holdings in shares of Cooper Companies by 35.5% in the fourth quarter. Covestor Ltd now owns 458 shares of the medical device company's stock worth $42,000 after buying an additional 120 shares during the period. Shell Asset Management Co. boosted its holdings in shares of Cooper Companies by 15.5% during the fourth quarter. Shell Asset Management Co. now owns 946 shares of the medical device company's stock worth $87,000 after purchasing an additional 127 shares during the period. UMB Bank n.a. boosted its holdings in shares of Cooper Companies by 16.7% during the first quarter. UMB Bank n.a. now owns 902 shares of the medical device company's stock worth $76,000 after purchasing an additional 129 shares during the period. Axxcess Wealth Management LLC boosted its holdings in shares of Cooper Companies by 1.9% during the first quarter. Axxcess Wealth Management LLC now owns 7,382 shares of the medical device company's stock worth $623,000 after purchasing an additional 140 shares during the period. Finally, Mitchell & Pahl Private Wealth LLC boosted its holdings in shares of Cooper Companies by 1.8% during the first quarter. Mitchell & Pahl Private Wealth LLC now owns 8,675 shares of the medical device company's stock worth $732,000 after purchasing an additional 157 shares during the period. Institutional investors and hedge funds own 24.39% of the company's stock.

Analysts Set New Price Targets

COO has been the topic of several recent research reports. Loop Capital set a $100.00 price objective on shares of Cooper Companies in a research report on Tuesday, June 17th. BNP Paribas Exane raised shares of Cooper Companies from a "neutral" rating to an "outperform" rating and set a $92.00 price target on the stock in a research report on Tuesday, July 22nd. Mizuho dropped their price target on shares of Cooper Companies from $105.00 to $90.00 and set an "outperform" rating on the stock in a research report on Wednesday, July 16th. UBS Group raised shares of Cooper Companies to a "buy" rating in a research report on Tuesday, June 17th. Finally, Wall Street Zen lowered shares of Cooper Companies from a "buy" rating to a "hold" rating in a research report on Saturday, July 12th. Three investment analysts have rated the stock with a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, Cooper Companies has an average rating of "Moderate Buy" and an average price target of $96.73.

Cooper Companies Stock Performance

COO traded down $0.18 during trading on Friday, reaching $73.26. 1,397,176 shares of the company's stock were exchanged, compared to its average volume of 1,661,885. The Cooper Companies, Inc. has a fifty-two week low of $65.00 and a fifty-two week high of $112.38. The company has a quick ratio of 1.23, a current ratio of 2.10 and a debt-to-equity ratio of 0.30. The business has a 50 day moving average price of $71.92 and a 200 day moving average price of $78.98. The company has a market capitalization of $14.65 billion, a P/E ratio of 35.56, a PEG ratio of 1.79 and a beta of 1.00.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its earnings results on Thursday, May 29th. The medical device company reported $0.96 EPS for the quarter, beating the consensus estimate of $0.93 by $0.03. The company had revenue of $1 billion for the quarter, compared to the consensus estimate of $995.12 million. Cooper Companies had a net margin of 10.39% and a return on equity of 9.60%. The firm's revenue for the quarter was up 6.3% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.85 EPS. As a group, analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.